Evidence map›Paper›PMID 40739692›Full record

ArticleCurrent pharmaceutical design2026

Quercetin and Citreorosein from

Tapas Ranjan Samala, Priyankar Sen

Abstract read
PubMed Publisher
In one paragraph

Article in Current pharmaceutical design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tapas Ranjan SamalaCentre for Bio-Separation Technology (CBST), Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.
Priyankar SenCentre for Bio-Separation Technology (CBST), Vellore Institute of Technology, Vellore, Tamil Nadu, 632014, India.

Funding

VIT Seed 2023-2025, RGEMS
6 · The paper itself

Abstract

introductionThe marine ecosystem, known for its diverse biochemistry and organisms adapted to harsh environments, contains numerous plants with promising anticancer potential. Halodule uninervis, a seagrass, contains a variety of bioactive compounds that provide various pharmacological properties. However, its potential anticancer effects against breast cancer remain largely unexplored.

methodsHRLC-MS analysis was conducted to identify the phytochemicals in the ethanolic extract of H. uninervis leaves. Several publicly available databases, including SEA, STP, MALACARDS, DISGENET, and OMIM, were used to identify target genes. Protein-protein interaction (PPI) networks, gene ontology, and pathway analysis were carried out through the STRING and DAVID databases. Molecular docking was performed by Autodock Vina, while molecular dynamics (MD) simulations and MMPBSA analyses were conducted using GROMACS, demonstrating the stability of the complexes up to 200 ns.

resultsThe top five therapeutically active phytochemicals were Quercetin, Arborinine, Methyl 3,4,5- trimethoxycinnamate, Citreorosein, and Scopolin. The five hub genes, AKT1, EGFR, TNF, ESR1, and GAPDH, were found by network analyses. Molecular docking and MD simulation demonstrate that Quercetin and Citreorosein are the best phytochemicals exhibiting the highest affinities to breast cancer targets AKT1, EGFR, and ESR1. DISCUSSION: For the first time, this

conclusionPhytochemicals, namely Quercetin and Citreorosein, may have an impact on the progression of breast cancer by binding to the key targets AKT1, ESR1, and EGFR.

Indexed as

AlismatalesAntineoplastic Agents, PhytogenicBreast NeoplasmsQuercetinErbB ReceptorsEstrogen Receptor alphaFemaleHumansMolecular Docking SimulationMolecular Dynamics SimulationPlant ExtractsPlant LeavesProto-Oncogene Proteins c-aktAKT1 protein, humanAntineoplastic Agents, PhytogenicEGFR protein, humanErbB ReceptorsESR1 protein, humanEstrogen Receptor alphaPlant ExtractsProto-Oncogene Proteins c-aktQuercetinBreast cancerHalodule uninervisMMPBSA.molecular dockingmolecular dynamic simulationnetwork pharmacologyphytochemicals

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.